ClinicalTrials.gg
RecruitingNCT06340009Updated Apr 1, 2024

MIME THERAPY vs MOTOR IMAGERY TECHNIQUE in Bell's Palsy

An interventional study of mime therapy and motor imagery in Bell Palsy, sponsored by Riphah International University. Recruiting at 1 site in Pakistan. Open to participants aged 20 Years to 40 Years. Per ClinicalTrials.gov, last updated 2024-04-01.

Sponsored by Riphah International University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Aug 2024, 2 years 2 months ago, but the record still lists the study as recruiting.
  • Started Mar 2024; still recruiting 2 years 7 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Randomized
Ages
20 Years to 40 Years
Sex
All
01

Study summary

Bell's palsy, characterized by unilateral paralysis/paresis of facial muscles, is a condition with a significant impact on individuals' lives. It was first identified by scientist Sir Charles Bell, and its sudden onset can lead to social, psychological, and emotional distress. Left untreated, Bell's palsy can have long-lasting effects on a patient's quality of life, including loss of facial muscle control, emotional stress, and communication difficulties. Rehabilitation protocols encompass various physical therapy techniques, among which Mime therapy and Motor imagery technique have shown promise.

Read the detailed description

While rehabilitation protocols have shown promise in enhancing facial muscle control, reducing disability, and preventing long-term complications, there remains a critical gap in the literature regarding the comparative effectiveness of various rehabilitation techniques. Currently, there is limited empirical evidence to guide healthcare professionals in selecting the most suitable rehabilitation approach for individual patients. The purpose of this study is to address this gap in knowledge by comparing two specific rehabilitation techniques: Mime therapy and Motor imagery technique. Understanding which of these rehabilitation techniques is more effective can significantly influence clinical practice and patient care. By conducting a systematic comparison, this study aims to provide evidence-based recommendations to healthcare professionals in selection of appropriate rehabilitation protocol for Bell's palsy patients.

02

Conditions studied

  • Bell Palsy

Browse trials for

03

In context

Bell Palsy

85 studies on the registry are indexed under Bell Palsy; 30 are open to participants now.

This study's planned enrollment of 44 is close to the median of 42 across 70 interventional studies indexed under Bell Palsy.

Browse Bell Palsy studies →

Lead sponsor

Riphah International University is the lead sponsor of 2,193 studies on the registry; 650 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 20-40 years
  • Both male and female
  • Patients diagnosed with Bell's Palsy
  • Paralysis/paresis of all muscle groups of one side of face

Exclusion criteria

Exclusion Criteria:

  • Patients diagnosed with facial palsy
  • Patients with impaired cognition
  • Patients diagnosed with other neurological diseases
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
44 participants (estimated)

Study arms

  • Experimental
    Mime therapy group

    Mime therapy focuses on improving facial symmetry and muscle control through self-massage, breathing exercises, eye and lip closure exercises, letter and word exercises, and expression exercises in front of mirror

    Other: mime therapy

  • Active comparator
    motor imagery group

    Motor imagery technique involves mental rehearsal of motor activities, activating similar brain regions as actual movements, which enhances neuroplasticity.

    Other: motor imagery

Interventions

  • Othermime therapy

    1. Facial Massage 2. Frowning 3. Close eyes 4. Smile 5. Fish Face 6. Eyebrow raising 7. Breathing exercise 8. Blow cheeks 9. Mouth opening and closing. 10. Moving lips side to side 11. Blow a candle. 12. Nasal flaring 13. Chewing exercise 14. Rinse mouth 15. Speaking vowels 16. Fill mouth with water 17. Fill rubber balloon 18. Sucking water with straw

  • Othermotor imagery

    1. Raising your eyebrows 2. Showing angry face 3. Closing and opening eyes 4. Pouting 5. Blowing cheeks 6. Smiling 7. Nasal flaring 8. Blowing candle 9. Deviating lips side to side 10. Chewing something 11. Speaking vowels

06

What researchers measure

Primary outcomes

  1. House-Brackmann Scale (HBS)

    A widely used scale to assess facial nerve dysfunction.Grades facial muscle function from I (normal) to VI (total paralysis). - Higher scores indicate more severe dysfunction.

    Time frame: week 6

  2. Facial Disability Index (FDI)

    A patient-reported outcome measure assessing the impact of facial palsy on daily life.Assesses physical, social, and emotional functioning - Uses a questionnaire. - Higher scores indicate a greater impact on daily life.

    Time frame: week 6

  3. Sunnybrook Facial Grading System

    An assessment tool for evaluating facial muscle function, including static and dynamic aspects.

    Time frame: week 6

  4. Synkinesis Assessment Questionnaire (SAQ)

    An assessment tool specifically designed to evaluate synkinesis- related symptoms. Assesses the presence and severity of synkinesis symptoms during voluntary actions. - Uses a questionnaire. - Higher scores indicate more severe synkinesis-related symptoms.

    Time frame: week 6

07

Study locations

1 of 1 sites recruiting
  • Muzaffar Hospital
    Sargodha, Pakistan
    Recruiting
    • Mulazam Imran, MS-NMPT* · Contact
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2024 (actual). Primary completion is estimated for Aug 2024, 5 months after the start.

Of 38 non-industry interventional studies with no phase under Bell Palsy, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 25. This study's planned 5 months is below that.

Counting every sponsor, half of 40 studies reached it within 10 months; a quarter within 3 and three quarters within 21.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 25, 2024
First posted
Apr 1, 2024
StartActual
Mar 22, 2024
Primary completionEst.
Aug 22, 2024
CompletionEst.
Aug 25, 2024
Last update
Apr 1, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 1, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06340009
Responsible party
Sponsor
First posted
Apr 1, 2024
Start date
Mar 22, 2024
Primary completion
Aug 22, 2024 (estimated)
Completion
Aug 25, 2024 (estimated)
Last update
Apr 1, 2024

Study contacts

Mulazam Imran, MS-NMPT*
Contact
mulazimimran04@gmail.com
03236791525
Ayesha Afridi, PhD*
Contact
afridi.ayesha@gmail.com
03325962212
Ayesha Afridi, PhD*
principal investigator · Riphah International University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion